AVTX vs JCI · P/E 0.0, $51.5M cap vs P/E 44, rev $23.60B
Avalo Therapeutics Inc (AVTX) versus Johnson Controls International PLC (JCI) — a side-by-side from cached financials, not a winner call.
Avalo Therapeutics Inc (AVTX) is a biotechnology company listed on US.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
Latest reported AVTX revenue for 2025-09-30 was $0. Net income was -$30.6M. AVTX currently screens at market cap $51.5M and trailing P/E 0.0.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
AVTX currently screens at market cap $51.5M and trailing P/E 0.0. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
Not investment advice. Open the AVTX and JCI stock pages for the full models.
Not investment advice.